HAPPY HOLIDAYS, ONE AND ALL!
We want to start things off this short trading week, by wishing everyone a happy holiday season, no matter how you celebrate!
This is traditionally a very low-key week for the markets, as most people are focused on enjoying their families or time off from work at this time. Especially with no major earnings reporters on the calendar, we expect a relatively subdued start to the week as well.
General Mills, Inc. GIS
One thing we do want to do is circle back to the call we made for the GIS options chain on Wednesday, which made a pretty good move into the end of the week, and will be high on our watchlist , as further gains are very possible.
We had highlighted the GIS 01/17 $55 Calls, and they subsequently made a very impressive move from .10-.29, marking a rise of 190% We will continue to keep an eye on this play, as GIS attempts to break the double top around the $54 mark. A break of that area will send these gains soaring.
Fresh Options Ideas:
Finally, it wouldn’t feel like the start of a fresh trading week without some fresh options speculation.
We’re going to radar the SPG 01/17 $145-150 Calls as the chart is in a prime bottom-bounce setup. We took it out to the January 17th’s to give ourselves ample time to witness what appears to be an impending rebound.
SDRL, ACHV, ONCY, CALA, YAYO, CPRX, FBIO, ITCI, LLEX
Amplitech Group, Inc. AMPG – Update
We were all over AMPG once again last week, as we have been since the beginning of April when we initiated coverage on the stock. The move on Friday followed the news that the company virtually doubled their yearly expected sales via acquisition of a long-established, privately-held company.
AMPG made a 15% intraday push to a new high of .063 which works out to an overall increase of 47% over the .043 low we observed on the day of our initial report on the company (04/01/19). It also came with the biggest single-session volume recorded over these past six weeks.
Friday’s gains pushed AMPG‘s market cap above the $3M mark, although we would argue that even at that price, the stock is still grossly undervalued at present. Especially when one considers that it’s notably less than the combined expected annual sales of AMPG and the pending acquisition target, which you can read about in the link to the news above, or in the 8-K filed this morning.
We remain excited for the future potential of this company, and its stock. Stay tuned for future updates and be sure to commence your own due diligence, starting at AmpliTechInc.com.
SPDR S&P500 ETF (SPY) – Recap
Along with our coverage of AMPG on Friday morning, we also included a fresh options idea for the SPY that was incredibly successful, and reinforcing the strength of our commitment to producing the very best ideas that we can.
We cited the SPY Weekly $284-285.50 Calls, and with the help of a strong second half of the day for the markets as a whole, yielded the following enormous gain opportunities:
$284 Calls – Range: .59-4.82 – Max Gain: 717%
$284.50 Calls – Range: .43-4.20 – Max Gain: 877%
$285 Calls – Range: .30-3.84 – Max Gain: 1180%
$285.50 Calls – Range: .21-3.29 – Max Gain: 1467%
TVIX, AXNX, IZEA, MOSY, SQQQ, CPRX
Catalyst Pharma Inc. CPRX
We saw a very impressive new high for a stock that we’ve been tracking off of a bottom since February 8th. CPRX traded for as little as 2.36 that day, and has never looked back, spending most of the 7 weeks since then in a general uptrend that really kicked into high gear yesterday.
The stock ultimately reached 5.25 before closing just a penny below that point. That works out to an upswing of 122% in well under two months’ time.
Axsome Therapuetics, Inc. AXSM
Speaking of stock runners, we called out AXSM for observation just last Thursday, and wanted to drop back in on it to comment regarding its performance thus far. From a low of 11.75 on Thursday morning, the stock has now reached as high as 16.38. That’s a relatively modest but still very respectable gain of 39% in a span of just three sessions.
SRNE, BPTH, BE, VLRX, ZUO, ATOS, BOXL, VTL, RWLK, ZDGE